BRPI1014435A2 - composto, processo de preparação de um composto, composições farmacêuticas, e, utilização de um composto. - Google Patents

composto, processo de preparação de um composto, composições farmacêuticas, e, utilização de um composto.

Info

Publication number
BRPI1014435A2
BRPI1014435A2 BRPI1014435A BRPI1014435A BRPI1014435A2 BR PI1014435 A2 BRPI1014435 A2 BR PI1014435A2 BR PI1014435 A BRPI1014435 A BR PI1014435A BR PI1014435 A BRPI1014435 A BR PI1014435A BR PI1014435 A2 BRPI1014435 A2 BR PI1014435A2
Authority
BR
Brazil
Prior art keywords
compound
preparing
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
BRPI1014435A
Other languages
English (en)
Inventor
Christophe Lanco
Dennis Bigg
Grégoire Prevost
Serge Auvin
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of BRPI1014435A2 publication Critical patent/BRPI1014435A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI1014435A 2009-04-17 2010-04-16 composto, processo de preparação de um composto, composições farmacêuticas, e, utilização de um composto. BRPI1014435A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901864A FR2944525B1 (fr) 2009-04-17 2009-04-17 Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
PCT/FR2010/000316 WO2010119194A1 (fr) 2009-04-17 2010-04-16 Dérivés d'imidazolidine-2,4-dione et leur utilisation comme médicament

Publications (1)

Publication Number Publication Date
BRPI1014435A2 true BRPI1014435A2 (pt) 2016-04-12

Family

ID=41258404

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014435A BRPI1014435A2 (pt) 2009-04-17 2010-04-16 composto, processo de preparação de um composto, composições farmacêuticas, e, utilização de um composto.

Country Status (18)

Country Link
US (1) US8624037B2 (pt)
EP (1) EP2419422B1 (pt)
JP (1) JP5571771B2 (pt)
KR (1) KR101699100B1 (pt)
CN (1) CN102428079B (pt)
AU (1) AU2010238381B2 (pt)
BR (1) BRPI1014435A2 (pt)
CA (1) CA2758638A1 (pt)
DK (1) DK2419422T3 (pt)
ES (1) ES2527617T3 (pt)
FR (1) FR2944525B1 (pt)
HK (1) HK1165796A1 (pt)
MX (1) MX2011010691A (pt)
PL (1) PL2419422T3 (pt)
PT (1) PT2419422E (pt)
RU (1) RU2555999C2 (pt)
UA (1) UA106884C2 (pt)
WO (1) WO2010119194A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106573921B (zh) * 2013-12-31 2019-05-07 博福-益普生（天津）制药有限公司 咪唑烷-2,4-二酮衍生物
RU2650678C2 (ru) * 2013-12-31 2018-04-17 Ипсен Фарма С.А.С. Новые производные имидазолидин-2,4-дионов
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途
CN117186027B (zh) * 2023-09-11 2024-04-19 上海蓝木化工有限公司 一种糖原合酶激酶-3抑制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1906492B2 (de) * 1969-02-10 1980-07-31 Bayer Ag, 5090 Leverkusen Carbonsäure-Derivate enthaltende Hydantoine und Polyhydantoine
US3903053A (en) * 1973-11-20 1975-09-02 Teijin Ltd Process for the preparation of polymers containing divalent hydantoin rings in their main chains
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
BRPI0715160A2 (pt) * 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso

Also Published As

Publication number Publication date
FR2944525B1 (fr) 2011-06-24
JP5571771B2 (ja) 2014-08-13
CN102428079B (zh) 2014-04-30
KR101699100B1 (ko) 2017-01-23
AU2010238381A1 (en) 2011-11-10
US20120095068A1 (en) 2012-04-19
KR20120027240A (ko) 2012-03-21
JP2012524051A (ja) 2012-10-11
DK2419422T3 (en) 2014-12-15
RU2555999C2 (ru) 2015-07-10
AU2010238381B2 (en) 2016-06-02
PL2419422T3 (pl) 2015-04-30
FR2944525A1 (fr) 2010-10-22
RU2011146533A (ru) 2013-05-27
EP2419422B1 (fr) 2014-10-15
PT2419422E (pt) 2015-01-02
ES2527617T3 (es) 2015-01-27
WO2010119194A1 (fr) 2010-10-21
MX2011010691A (es) 2011-11-04
EP2419422A1 (fr) 2012-02-22
CA2758638A1 (fr) 2010-10-21
UA106884C2 (uk) 2014-10-27
US8624037B2 (en) 2014-01-07
HK1165796A1 (en) 2012-10-12
CN102428079A (zh) 2012-04-25

Similar Documents

Publication Publication Date Title
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
BRPI1006162A2 (pt) "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI1010933A2 (pt) processo para a preparação de um pó, e, composto
BRPI1013561A2 (pt) Processo para a preparação de alogliptina
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
BRPI0821801A2 (pt) Zeólito e processo de preparação de um zeólito.
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BR112012016201A2 (pt) ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI1011130A2 (pt) composto organometálico, processo de preparação de um composto organometálico,e, utilização de um composto organometálico.
BRPI1007654A2 (pt) composto, processo para a obtenção de um composto de fórmula geral e composição farmacêutica
BRPI1007186A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BRPI1014436A2 (pt) composto, processo de preparação de um composto, intermediário, composições farmacêuticas, e, utilização de um composto.
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário
BRPI1014125A2 (pt) composto, composição farmacêutica, e, uso de um composto.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2510 DE 12-02-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.